Newsletter number 32 – April 2012

This newsletter contains articles on the following subjects:

• Revocation due to lack of inventive step of Pfizer patent on polymorph of magnesium atrovastatin.
• Bad faith, nullity of marks and infringement: Nuances of the CTM Court criteria.
• The defendant’s lack of cooperation cannot benefit him when quantifying the damages.
• Condemnatory Judgment in a criminal case of imitation of a well-known trademark, the importer having invoked a cover registration.